About Perthera
Perthera is a company based in Mclean (United States) founded in 2012.. Perthera has raised $17.02 million across 5 funding rounds from investors including Pilot Growth Equity Partners. The company has 13 employees as of December 31, 2022. Perthera offers products and services including Perthera Report, Virtual Molecular Tumor Board, and RWE Data Pipeline. Perthera operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Tempus, Poseida Therapeutics and Juno Therapeutics, among others.
- Headquarter Mclean, United States
- Employees 13 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Perthera Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.02 M (USD)
in 5 rounds
-
Latest Funding Round
$4.47 M (USD), Series A
Sep 30, 2022
- Investors
-
Employee Count
13
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Perthera
Perthera offers a comprehensive portfolio of products and services, including Perthera Report, Virtual Molecular Tumor Board, and RWE Data Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Ranks therapy options for cancer patients using AI analysis.
Facilitates physician collaboration for oncology expertise.
Processes real-world evidence for clinical trial matching.
Unlock access to complete
Unlock access to complete
Funding Insights of Perthera
Perthera has successfully raised a total of $17.02M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $4.47 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $4.5M
-
First Round
First Round
(11 Aug 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Series A - Perthera | Valuation |
investors |
|
| Jan, 2019 | Amount | Series A - Perthera | Valuation |
investors |
|
| Jun, 2016 | Amount | Series A - Perthera | Valuation | Pilot Growth Equity |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Perthera
Perthera has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Pilot Growth Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth equity investments are provided to technology entrepreneurs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Perthera
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Perthera
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Perthera Comparisons
Competitors of Perthera
Perthera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Tempus, Poseida Therapeutics and Juno Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
AI-based precision medicine solutions for oncology are provided.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Perthera
Frequently Asked Questions about Perthera
When was Perthera founded?
Perthera was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is Perthera located?
Perthera is headquartered in Mclean, United States. It is registered at Mclean, Virginia, United States.
Is Perthera a funded company?
Perthera is a funded company, having raised a total of $17.02M across 5 funding rounds to date. The company's 1st funding round was a Series A of $9.17M, raised on Aug 11, 2015.
How many employees does Perthera have?
As of Dec 31, 2022, the latest employee count at Perthera is 13.
What does Perthera do?
Perthera was founded in 2012 and is based in McLean, United States, operating in the biotechnology sector focused on oncology. Personalized molecular profiling of tumors is facilitated through genomics and proteomics analyses. The PrecisOn process is employed to integrate these analyses with patient medical history in the Expert Oncologist system (ExpO), a database that incorporates current clinical research and drug information for oncologist guidance.
Who are the top competitors of Perthera?
Perthera's top competitors include Tempus, Juno Therapeutics and Personalis.
What products or services does Perthera offer?
Perthera offers Perthera Report, Virtual Molecular Tumor Board, and RWE Data Pipeline.
Who are Perthera's investors?
Perthera has 1 investor. Key investors include Pilot Growth Equity Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.